DBR Biotech
DBR Biotech is a Brazilian B2B distributor, founded 1995, representing 18+ international laboratory brands including Cytek Biosciences spectral flow cytometry equipment and BioLegend/Exbio reagents for clinical, research, and pharmaceutical laboratories across Brazil.
- Company typePrivate
- Founded1995
- HeadquartersSão Bernardo do Campo, Brazil
- Headcount11–50
- GTM typeB2B
- OfferingServices
What DBR Biotech does
DBR Biotech is a privately held Brazilian B2B laboratory solutions distributor headquartered in São Bernardo do Campo, São Paulo, operating continuously since 1995 with 15 employees. The company functions as the exclusive Brazilian representative and distributor for 18+ international biotechnology brands, generating revenue through transactional margins on equipment sales, reagent distribution, and consumable supply to clinical, toxicological, pharmaceutical, cosmetics, and life science research laboratories.
The core of DBR Biotech's product offering centers on Cytek Biosciences spectral flow cytometry equipment — including the Aurora, Northern Lights, Aurora CS, and Aurora Evo systems, which leverage Cytek's proprietary Full Spectrum Profiling (FSP) technology to enable up to 40-color high-parameter cellular analysis without filter changes. This equipment franchise is complemented by a broad reagents and consumables portfolio spanning monoclonal antibodies (BioLegend, Exbio, Affinity — over 4,000 SKUs from Exbio alone), ELISA kits (Elabscience, FineTest, Elk Biotechnology, U-CyTech), exosome detection assays (Immunostep), calibration particles (Spherotech), and clinical diagnostics platforms (QuidelOrtho, Randox, IBL International, DneDX).
DBR Biotech operates a sales-led, event-driven go-to-market focused on direct B2B sales to institutional customers, active sponsorship and participation in scientific congresses (SBI, IMMUNO Búzios, CIFARP), university training workshops, and product demonstrations at major Brazilian research and healthcare institutions including USP, Unifesp, FIOCRUZ, Hospital Amaral Carvalho, Hospital da Criança de Brasília, ICESP, and Hospital das Clínicas de Botucatu. Pricing is quote-based and not publicly disclosed; products are typically held in ready-for-immediate-delivery inventory. The company is privately held with no disclosed investors, funding rounds, or revenue figures.
DBR Biotech firmographics
Firmographics- Name
- DBR Biotech
- Legal name
- DBR Biotech
- Website
- https://dbrbiotech.com.br
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- DBR Biotech is a Brazilian B2B distributor, founded 1995, representing 18+ international laboratory brands including Cytek Biosciences spectral flow cytometry equipment and BioLegend/Exbio reagents for clinical, research, and pharmaceutical laboratories across Brazil.
- Ownership category
- akta.pro rank
DBR Biotech industry classification
Industry- Product category
- Laboratory Products Distribution
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Drugs and Druggists' Sundries Merchant Wholesalers (424210), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Laboratory Analytical Instruments (3826), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
Keywords
Where DBR Biotech is headquartered
LocationHeadquarters
- HQ city
- São Bernardo do Campo
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
DBR Biotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Supply Chain, Technology or R&D
Revenue model
- Laboratory Products Distribution: DBR Biotech generates revenue by distributing laboratory products including monoclonal antibodies, reagents, ELISA kits, consumables, and equipment to clinical, research, and industrial laboratories in Brazil. The company operates as a distributor/representative of international brands, earning margins on product sales.
- Equipment Sales and Support: Sales and distribution of flow cytometry equipment including Cytek Aurora, Northern Lights, Aurora CS, and Aurora Evo systems. Includes installation, training, and technical support services.
- Spectral Flow Cytometry Instruments and Accessories: Distribution of Spherotech calibration particles, NordicMUbio antibodies, and other consumables for flow cytometry applications.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
DBR Biotech product offering
Product offeringCore offering
DBR Biotech distributes and represents international laboratory product brands in Brazil, supplying clinical and research laboratories with flow cytometry equipment, monoclonal antibodies, ELISA kits, reagents, consumables, and point-of-care diagnostics. Since 2021 it is the first official Brazilian distributor of Cytek Biosciences spectral flow cytometers (Aurora, Northern Lights, Aurora CS, Aurora Evo) and represents 18+ partner brands including BioLegend, Exbio, Immunostep, Affinity, Cedarlane, Elabscience, Spherotech, and others. Products are typically available ready for immediate delivery to clinical, toxicological, pharmaceutical, cosmetics, and life science research laboratories.
Product overview
DBR Biotech is a laboratory solutions distributor operating since 1995, representing multiple international brands in Brazil. The core offering centers on Cytek Biosciences spectral flow cytometry equipment (Cytek Aurora, Northern Lights, Aurora CS, and Aurora Evo analyzers) complemented by a comprehensive portfolio of research reagents and consumables from partner brands. Product categories span Research (antibodies, ELISA kits, flow cytometry reagents), Diagnostics (point-of-care, clinical analyzers), Consumables, and Equipment. Key reagent partners include BioLegend (ISO 13485 certified), Exbio (4,000+ monoclonal antibodies), Immunostep (exosome detection kits), Affinity, Cedarlane, Nordic-MUbio, and Spherotech, among others. The company serves clinical analysis, toxicology, pharmaceutical, cosmetics, and life science (clinical and scientific research) sectors with products typically available for immediate delivery.
Differentiator
Problem solved
Functional benefit
Products and services
- Cytek Aurora
Quantifiable outcome
- Over 4,000 monoclonal antibody and reagent products available from Exbio alone for flow cytometry applications
- +1 more outcomes
Companies that use DBR Biotech
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles3 records
DBR Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
DBR Biotech partnerships and signals
Strategic signalPartnerships
18 partnerships are on record, tiered core and minor.
- Cytek BiosciencescoreDBR Biotech is the first official distributor of Cytek Biosciences in Brazil since 2021. The company represents the full line of spectral flow cytometry equipment including Cytek Aurora, Northern Lights, Aurora CS, and Aurora Evo systems. Cytek's Full Spectrum Profiling (FSP) technology represents an innovative approach inspired by telecommunications industry technology.
- BioLegendcoreBioLegend is a world reference in innovative reagents for scientific research, recognized for expertise in Immunology, Neuroscience, Cancer, Stem Cells, and Cell Biology. The company offers ISO 13485:2016 certified products. DBR Biotech represents BioLegend products in Brazil.
- ExbiocoreExbio is a leading producer of monoclonal antibodies and reagents with over 4,000 products for flow cytometry analysis. The company specializes in multiparametric analysis of human cellular markers for research and clinical applications. DBR Biotech distributes Exbio products exclusively in Brazil.
- ImmunostepcoreImmunostep is a Spanish company founded in 2001 specializing in flow cytometry products. They develop comprehensive products for clinical research and diagnostic development, including exosome detection kits (ExoELISA-Step KIT and ExoStep). DBR Biotech is the official distributor of Immunostep in Brazil.
- SpherotechminorSpherotech specializes in manufacturing micro and nanoparticles including polystyrene fluorescent particles, paramagnetic beads, and gold nanoparticles for flow cytometry calibration, compensation, and cell counting applications.
- Affinity BiosciencesminorAffinity Biosciences is a pioneer in Life Science with over 13,000 antibodies, 15,000 peptide types, and 2,000 phospho-antibodies in stock for cell signaling research including AKT, AMPK, NF-KappaB, and TGF-beta pathways.
- CedarlaneminorCedarlane has over 50 years of experience producing complements and is a world leader in complement reagents with high activity and low background cytotoxicity for bactericidal assays, HLA tissue typing, and cytotoxicity assays.
- ElabscienceminorElabscience specializes in immunodiagnostics with various certifications, focused on scientific research offering antibodies, proteins, ELISA kits, and CLIA kits.
- Elk BiotechnologyminorElk Biotechnology specializes in Life Science and immunological research with over 7,000 ELISA kits. DBR Biotech represents their products in Brazil. Elk received the CiteAb Award ELISA Kit Supplier to Watch in 2026.
- FineTestminorFineTest offers an extensive line of ELISA kits and research reagents including high-quality primary and secondary antibodies and recombinant proteins, certified to ISO9001:2015.
- IBL International (Grupo Tecan)minorIBL International is a pioneer in saliva diagnostics by ELISA technique with over 35 years of experience. Part of Tecan Group since 2014, they specialize in rare disease diagnostics including salivary hormones, neurotransmitters, and neurodegenerative disease markers. DBR Biotech is the exclusive Brazilian supplier.
- NordicMUbiominorNordicMUbio develops and manufactures high-quality antibodies for R&D including cellular adhesion, nuclear proteins, and cytoskeleton. They acquired An Der Grub Bio Research in 2013, adding flow cytometry products including FIX & PERM kit for cell fixation and permeabilization.
- MP BiomedicalsminorMP Biomedicals produces and distributes Life Science products, fine chemicals, diagnostic kits, and dosimetry products. They offer the FastPrep family of benchtop instruments using beat technology for lysing, homogenizing, and grinding samples in 40 seconds or less.
- QuidelOrthominorQuidelOrtho provides clinical laboratory testing platforms for infectious diseases, cardiology, and endocrinology. They reinvented clinical laboratory flexibility with patented dry slide technology.
- RandoxminorRandox is a world leader in in vitro diagnostics with over 145 countries served. They develop diagnostic solutions for clinical, research, molecular, food testing, forensic toxicology, and veterinary laboratories.
- U-CyTech BiosciencesminorU-CyTech is a Dutch biotechnology company specializing in cytokine biology research. They manufacture innovative cytokine systems for ELISA, ELISPOT, and FluoroSpot techniques for humans, monkeys, and rodents.
- Agilent DakominorAgilent is an American biotechnology company with over 20 years of market experience. They offer monoclonal and polyclonal antibodies compatible with most flow cytometers, along with specific kits and controls.
- DneDXminorDneDX develops Point of Care and Self Testing technologies. Founded in 2014 and based in Bristol, UK, they offer solutions in coagulation, infectious diseases, hormones, and metabolism with extensive qualitative and quantitative assays.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
DBR Biotech competitors and assessment
Company assessmentBroad incumbents
- Thermo Fisher Scientific: Operates a global lab products distribution platform (Fisher Scientific) plus in-house flow cytometry (Invitrogen antibodies, Attune cytometers) and competes with many of DBR's principals. Comparable as a one-stop supplier that DBR's customers could alternatively use.
- Sysmex: Global leader in hematology and clinical flow cytometry with strong direct presence in Brazil through its own distribution, competing for the same clinical flow cytometry applications where DBR has installed Northern Lights systems at Brazilian hospitals.
- Agilent Technologies: Owns the Dako flow cytometry antibody line (a DBR principal) and sells a broad portfolio of lab instruments and reagents into Brazil, providing both partnership and competitive overlap with DBR's portfolio.
- BD Biosciences: Global leader in flow cytometry instrumentation and reagents (BD FACSCelesta, BD Symphony) with direct commercial presence in Brazil, directly competing for the same flow cytometry wallet share DBR services through Cytek.
- Revvity (formerly PerkinElmer Life Sciences): Owns BioLegend (a DBR principal) and sells flow cytometry reagents, immunoassays, and instruments into Brazil through direct channels, creating supplier-competition dynamics with DBR's BioLegend distribution business.
- Beckman Coulter Life Sciences: Major flow cytometry and laboratory instrument manufacturer (CytoFLEX, NAVIOS) with established Brazilian distribution, competing head-to-head with DBR's Cytek portfolio across Brazilian clinical and research customers.
- Avantor (VWR): Global laboratory products distributor with deep presence across Latin America, distributing consumables, reagents, and equipment to research and clinical labs — directly comparable distribution model to DBR but at vastly larger scale and breadth.
Direct peers
- Bio-Rad Laboratories: Direct competitor in flow cytometry (ZE5 cell analyzer) and a major reagent/antibody producer with Brazilian distribution, targeting the same immunology, cell biology, and life-science research customers as DBR.
- Miltenyi Biotec: Flow cytometry (MACSQuant) and cell-separation specialist with active commercial presence in Brazil, competing for the same immunology, oncology, and cell-therapy research customers that DBR serves through its spectral flow portfolio.
Emerging players
- LGC Biosearch Technologies: Genomics and life-science reagent supplier with growing Latin American presence; comparable as a specialty life-science distributor competing for research-lab reagent budgets adjacent to DBR's flow cytometry franchise.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
DBR Biotech social profiles
Digital presenceDBR Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
DBR Biotech leadership team
Management profileNumber of profiles
Profiles1 record
DBR Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DBR Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DBR Biotech
What does DBR Biotech do?
DBR Biotech distributes and represents international laboratory product brands in Brazil, supplying clinical and research laboratories with flow cytometry equipment, monoclonal antibodies, ELISA kits, reagents, consumables, and point-of-care diagnostics. Since 2021 it is the first official Brazilian distributor of Cytek Biosciences spectral flow cytometers (Aurora, Northern Lights, Aurora CS, Aurora Evo) and represents 18+ partner brands including BioLegend, Exbio, Immunostep, Affinity, Cedarlane, Elabscience, Spherotech, and others. Products are typically available ready for immediate delivery to clinical, toxicological, pharmaceutical, cosmetics, and life science research laboratories.
Is DBR Biotech a public or private company?
DBR Biotech is a private company. It is classified as unknown and is currently operating.
When was DBR Biotech founded?
DBR Biotech was founded in 1995. It employs 11 to 50 people.
Where is DBR Biotech based?
DBR Biotech is headquartered in São Bernardo do Campo, Brazil, in the Latin America region.
How does DBR Biotech make money?
Three revenue lines are on record. Laboratory Products Distribution is the primary driver. The others are equipment Sales and Support and spectral Flow Cytometry Instruments and Accessories.
Who are DBR Biotech's main competitors?
Broad incumbents on record are Thermo Fisher Scientific, Sysmex, Agilent Technologies, BD Biosciences, Revvity (formerly PerkinElmer Life Sciences), Beckman Coulter Life Sciences and Avantor (VWR). Direct peers are Bio-Rad Laboratories and Miltenyi Biotec. LGC Biosearch Technologies is listed as an emerging player.
Does DBR Biotech have an API?
No public API is recorded for DBR Biotech.
What industry is DBR Biotech in?
DBR Biotech's product category is Laboratory Products Distribution. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 334516 and its SIC code is 3826.